Live feed
Filing
SC 13G
SC 13G0001104659-20-118184·GILEAD SCIENCES, INC.
Schedule 13G ownership disclosure
JOUNCE THERAPEUTICS INC
Security class unavailable · CUSIP: 481116101
Event date: 2020-10-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,539,727
- Percent of class
- 13.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-118184
- Form type
- SC 13G
- Filer
- GILEAD SCIENCES, INC.
- CIK
- CIK 882095
- Filed
- Oct 26, 2020
- Reporting period
- Oct 16, 2020
- Description
- Schedule 13G beneficial ownership